In addition to Rob Flippo, CEO of MobileHelp, the MobileHelp board of directors is comprised of individuals who, on the basis of their knowledge and professional acumen, make valuable contributions to the overall business. Board candidates are considered based upon various criteria, including their broad-based business skills and experience in relevant areas critical to our business, prominence and reputation in their professions, and personal integrity and judgment.
Joe Cammarosano joined Abry in 2016. He is responsible for analyzing new investments, working with portfolio companies and supporting sale transactions. Prior to joining Abry, he was a member of the Natural Resources Group at Deutsche Bank. Joe graduated magna cum laude from the University of Notre Dame, where he earned a Bachelor of Business Administration in Finance and Economics.
At Mass General Brigham (Partners HealthCare), Dr. Joe Kvedar has focused on driving innovation, creating the market, and gaining acceptance for telehealth for nearly three decades. He is now applying his expertise, insights, and influence to advance the adoption of telehealth and virtual care technologies at the national level. Dr. Kvedar is Professor of Dermatology at Harvard Medical School and President of the American Telemedicine Association (ATA). He is co-chair the American Medical Association's (AMA) Digital Medicine Payment Advisory Group (DMPAG), which works to ensure widespread coverage of telehealth and remote patient monitoring, and successfully established several new provider codes for telehealth reimbursement through the CPT process. Dr. Kvedar is also a member of the AAMC’s (Association of American Medical Colleges) telehealth committee, creating tools that will enable medical schools and residency programs to integrate telehealth into the training of future practitioners. He is the author of two books on digital health: The Internet of Healthy Things and The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan.
Harry L. Leider, MD, MBA currently is the Chief Medical Officer and Executive Vice President of Gelesis, a biotech firm focused on obesity and major diseases of the gastrointestinal tract. With over 25 years of experience as a senior healthcare executive in a variety of innovative healthcare companies, his passion is leveraging his business, leadership, and clinical skills to create programs, services, and intellectual property that improve the health of large populations at scale. Prior to joining Gelesis, Dr. Leider’s role as Chief Medical Officer and Group Vice President at Walgreens provided a unique platform to impact the 6 million customers who visited a Walgreens store each day, as well as the 2 million customers who interacted with Walgreens digitally.
Prior to joining Walgreens, Dr. Leider was Chief Medical Officer and Senior Vice President of Ameritox, a national specialty laboratory that provides medication monitoring services to physicians that treat chronic pain and serious mental illness. Previously, he was Chief Medical Officer of XLHealth, a national Medicare Advantage plan that served seniors with common chronic illnesses. Dr. Leider speaks frequently to national audiences and is a core faculty member for the American Association of Physician Leadership where he also served as a recent past-President and Board Chairman. Dr. Leider has also served on the faculty of Harvard Medical School and the Johns Hopkins Carey School of Business.
Mike Meyers has served in the role of CFO for both public and private companies, with extensive experience in financial and operations management, as well as a track record of success in significantly growing enterprise value. Using his extensive M&A and capital raising experience, he has been involved in multiple acquisitions and divestitures and raising private equity and public and private debt. He has taken a business from early stage, venture capital backed, through private equity to becoming a public company, and has experience in a variety of industries including: recurring revenue businesses, manufacturing, retail, security alarm monitoring and home automation/IoT.
Rob Nicewicz joined Abry in 2009. He has evaluated, overseen, financed, and sold numerous companies in Abry’s targeted sectors. Rob’s areas of focus have included communications, machine-to-machine, healthcare IT and data centers. Prior to joining Abry, Rob was a member of the Technology, Telecom & Digital Media group of Harris Williams & Co. Rob graduated magna cum laude from Babson College.
Dawn Perdew is a 20-year marketing industry veteran, whose company works with global brands to help them develop capabilities in strategy, search marketing, business intelligence, customer experience, technology optimization, analytics, and digital media buying and planning. Since early 2000, Ms. Perdew has worked with more than 100 well-known businesses to accelerate growth across multiple consumer verticals through the use of an integrated marketing approach. Her client list includes: P&G, Nestle, J&J, AARP, Dr. Scholl’s and Inogen.
Tomer Yosef-Or is a Partner with Abry Partner. He joined the firm in 2005 and since then has originated, supervised, and sold numerous companies in Abry’s targeted sectors. Areas of focus have included IoT communication, data centers, digital media, cyber security, Healthcare IT, and consumer services. Prior to joining Abry, Tomer was a member of the Financial Institution Group at Bear Stearns. Previously, he was a member of the Securitization Transaction Group at Deloitte & Touche. Tomer is an honors graduate of the Rutgers Business School New Brunswick Undergraduate Program.
